File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Subcutaneous extralesional triamcinolone acetonide injection versus conservative management in the treatment of chalazion

TitleSubcutaneous extralesional triamcinolone acetonide injection versus conservative management in the treatment of chalazion
Authors
Issue Date2006
PublisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html
Citation
Hong Kong Medical Journal, 2006, v. 12 n. 4, p. 278-281 How to Cite?
AbstractObjective. To compare the efficacy of subcutaneous extralesional triamcinolone acetonide injection versus conservative treatment for chalazion. Design. Randomised controlled trial. Setting. Eye clinics of two regional hospitals in Hong Kong. Patients. Patients over 18 years old presenting with primary chalazion were randomised into two groups. In group 1, 12 patients were treated with lid hygiene, warm compresses, and chloramphenicol 1% ointment 4 times a day. In group 2, 16 patients were treated with 0.3 mL triamcinolone acetonide (10 mg/mL) injection to the subcutaneous tissue extralesionally via the percutaneous route. Exclusion criteria were: acutely infected chalazion with preseptal cellulitis, recurrent chalazion, small chalazion (≤2 mm), and prior treatment to chalazion. Main outcome measures. Size of chalazion, recurrence of chalazion, intraocular pressure, and complications from treatment, including skin pigmentary change or atrophy and pyogenic granuloma. Results. There was a clinically and statistically significant difference between the success rates in group 1 (58.3%) and group 2 (93.8%). In group 1, the mean prior duration of chalazion before treatment was significantly shorter in success cases than in failed cases. One patient with multiple chalazia in group 2 developed hypopigmentary skin changes at one treatment site. Conclusion. Subcutaneous extralesional triamcinolone acetonide injection was more effective than conservative treatment for chalazion.
Persistent Identifierhttp://hdl.handle.net/10722/176451
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279
References

 

DC FieldValueLanguage
dc.contributor.authorChung, CFen_US
dc.contributor.authorLai, JSMen_US
dc.contributor.authorLi, PSHen_US
dc.date.accessioned2012-11-26T09:11:22Z-
dc.date.available2012-11-26T09:11:22Z-
dc.date.issued2006en_US
dc.identifier.citationHong Kong Medical Journal, 2006, v. 12 n. 4, p. 278-281en_US
dc.identifier.issn1024-2708en_US
dc.identifier.urihttp://hdl.handle.net/10722/176451-
dc.description.abstractObjective. To compare the efficacy of subcutaneous extralesional triamcinolone acetonide injection versus conservative treatment for chalazion. Design. Randomised controlled trial. Setting. Eye clinics of two regional hospitals in Hong Kong. Patients. Patients over 18 years old presenting with primary chalazion were randomised into two groups. In group 1, 12 patients were treated with lid hygiene, warm compresses, and chloramphenicol 1% ointment 4 times a day. In group 2, 16 patients were treated with 0.3 mL triamcinolone acetonide (10 mg/mL) injection to the subcutaneous tissue extralesionally via the percutaneous route. Exclusion criteria were: acutely infected chalazion with preseptal cellulitis, recurrent chalazion, small chalazion (≤2 mm), and prior treatment to chalazion. Main outcome measures. Size of chalazion, recurrence of chalazion, intraocular pressure, and complications from treatment, including skin pigmentary change or atrophy and pyogenic granuloma. Results. There was a clinically and statistically significant difference between the success rates in group 1 (58.3%) and group 2 (93.8%). In group 1, the mean prior duration of chalazion before treatment was significantly shorter in success cases than in failed cases. One patient with multiple chalazia in group 2 developed hypopigmentary skin changes at one treatment site. Conclusion. Subcutaneous extralesional triamcinolone acetonide injection was more effective than conservative treatment for chalazion.en_US
dc.languageengen_US
dc.publisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.htmlen_US
dc.relation.ispartofHong Kong Medical Journalen_US
dc.subject.meshAdulten_US
dc.subject.meshChalazion - Drug Therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInjections, Subcutaneousen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshTriamcinolone Acetonide - Administration & Dosageen_US
dc.titleSubcutaneous extralesional triamcinolone acetonide injection versus conservative management in the treatment of chalazionen_US
dc.typeArticleen_US
dc.identifier.emailLai, JSM: laism@hku.hken_US
dc.identifier.authorityLai, JSM=rp00295en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.pmid16912354-
dc.identifier.scopuseid_2-s2.0-33747847774en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33747847774&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume12en_US
dc.identifier.issue4en_US
dc.identifier.spage278en_US
dc.identifier.epage281en_US
dc.publisher.placeHong Kongen_US
dc.identifier.scopusauthoridChung, CF=34979879000en_US
dc.identifier.scopusauthoridLai, JSM=7401939748en_US
dc.identifier.scopusauthoridLi, PSH=14219399300en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats